News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Amgen buys deCode Genetics. CMS opens proposed decision memo on PET radiopharmaceuticals. More news briefs.
You may also be interested in...
Reimbursement In Brief
CMS issues proposed decision memo on ocular photodynamic therapy and opens national coverage analyses for cardiac pacemakers and bariatric surgery. GAO denies Palmetto’s Medicare award protest. More reimbursement news.
Medicare Coverage Of PET Pharmaceutical Agents Needs Revamp, Industry Says
A broad range of stakeholders are asking CMS to remove national non-coverage language for newly approved radiopharmaceuticals used in positron emission tomography to allow speedier access to new tools for diagnosing Alzheimer’s and other diseases.
CMS In Brief
Updates from the 2013 Medicare physician fee schedule and hospital outpatient prospective payment system proposed rules, and other CMS news.